Protagonist Therapeutics Inc buy JPMorgan Chase & Co.
Start price
28.02.24
/
50%
€84.50
Target price
28.02.25
€34.13
Performance (%)
-
End price
01.03.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% | 130.874% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€70.20
07.11.26
07.11.26
22.46%
10.04.26
10.04.26
Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€92.26
19.03.27
19.03.27
-3.98%
10.04.26
10.04.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.03.25
04.03.25
€54.07
04.03.26
04.03.26
66.34%
05.03.26
05.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.02.25
04.02.25
€51.09
04.02.26
04.02.26
40.59%
05.02.26
05.02.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
25.07.24
25.07.24
€44.18
25.07.25
25.07.25
-4.16%
26.07.25
26.07.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€84.50
25.09.23
25.09.23
€32.11
25.09.24
25.09.24
-
26.09.24
26.09.24

